Idarucizumab in High-risk Thoracic Surgery

Idarucizumab in High-risk Thoracic Surgery

Direct oral anticoagulants have suggested a favorable profile compared with vitamin K antagonists. However, the lack of treatment to reverse the effect of direct oral anticoagulants has limited its use in some patients who require rapid reversal of anticoagulation, as those included in the transplan...

Full description

Bibliographic Details
Main Authors: R L�pez Vilella, J Sanz S�nchez, I S�nchez L�zaro, E Marqu�s-Sul�, J Rueda Soriano, L Almenar Bonet
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2018-04-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Heart-lung transplantation
Anticoagulants
Idarucizumab
Online Access:http://www.ijotm.com/ojs/index.php/IJOTM/article/view/526

Similar Items

Similar Items